Barry Bunin, PhDFounder & CEOCollaborative Drug Discovery AI + Machine Learning = Inflection Point for Biopharma. That’s the 2023 forecast from FIERCE Pharma, which points to a flood of AI and machine learning products. The article describes new offerings from a number of companies seeking to “r...
Drug Discovery Industry Roundup with Barry Bunin — January 4, 2023 Drug Discovery Industry Roundup with Barry Bunin — January 4, 2023 Barry Bunin, PhD Founder & CEO Collaborative Drug Discovery AI + Machine Learning = Inflection Point for Biopharma. That’s the 2023 forecast from FIERCE Pharma, which points to a flood of AI and machine learning products. The article describes new offerings from a number… by Brian Moore, CDD Webpage: https://ift.tt/xaq5Biu Bengaluru: January 05, 2023 at 01:23AM |
Zastra's JournalArchives
April 2023
Categories |